{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:31:14Z","timestamp":1791153074984,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.fertnstert.2014.10.038","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T01:33:06Z","timestamp":1419384786000},"page":"519-527.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids"],"prefix":"10.1016","volume":"103","clinical-trial-number":[{"clinical-trial-number":"nct01629563","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jacques","family":"Donnez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hudecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Matule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Arhendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Zatik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaneta","family":"Kasilovskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai Cristian","family":"Dumitrascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.J.M.","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Bestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Terrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Osterloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Loumaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.10.038_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/humrep\/17.6.1424","article-title":"What are the implications of myomas on fertility? A need for a debate?","volume":"17","author":"Donnez","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJMe1114043","article-title":"Uterine fibroids and evidence-based medicine. Not an oxymoron","volume":"366","author":"Stewart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0015-0282(16)60723-9","article-title":"Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography","volume":"51","author":"Donnez","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib5","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0015-0282(16)57729-2","article-title":"Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri","volume":"64","author":"Scialli","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib7","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/humrep\/14.11.2844","article-title":"Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy","volume":"14","author":"Nisolle","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-09-2612","article-title":"Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells","volume":"70","author":"Yin","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib9","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover study","volume":"76","author":"Carr","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2012.695775","article-title":"Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment","volume":"8","author":"Melis","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jcpt.12065","article-title":"Ulipristal acetate\u2014safety and pharmacokinetics following multiple doses of 10\u201350 mg per day","volume":"38","author":"Pohl","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-128X(03)00130-2","article-title":"Pharmacologic properties of CDB(VA)-2914","volume":"68","author":"Gainer","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib15","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1155\/2012\/436174","article-title":"Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in\u00a0vivo","volume":"2012","author":"Horak","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib16","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.humpath.2010.11.003","article-title":"Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone","volume":"42","author":"Fiscella","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/modpathol.2008.204","article-title":"Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator","volume":"22","author":"Ioffe","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0029-7844(95)00062-V","article-title":"A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss","volume":"85","author":"Janssen","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: Comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib30","first-page":"75","volume":"Ch 4","author":"Hollander","year":"1973"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib31","first-page":"33","article-title":"Influence of menopausal status on frequency and pathohistological features of endometrial hyperplasia and carcinoma in patients with abnormal uterine bleeding","volume":"47","author":"Milosevic","year":"2008","journal-title":"Acta Med Medianae"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib32","unstructured":"Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid (Online); 2011:pii0814."},{"key":"10.1016\/j.fertnstert.2014.10.038_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/humrep\/12.3.436","article-title":"Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability","volume":"12","author":"Caird","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib34","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality\u00a0of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(16)59763-5","article-title":"A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri","volume":"49","author":"Friedman","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0015-0282(16)53578-X","article-title":"Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate","volume":"53","author":"Rein","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib39","first-page":"1221","article-title":"Intrauterine therapy with levonorgestrel-releasing IUD in hypermenorrhea secondary to uterine fibroids","volume":"71","author":"Starczewski","year":"2000","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0301-2115(01)00555-3","article-title":"The effect on menstrual blood loss in women with uterine fibroids of a novel \u201dframeless\u201c intrauterine levonorgestrel-releasing drug delivery system: a pilot study","volume":"102","author":"Wildemeersch","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.10.038_bib41","unstructured":"Mirena. Summary of product characteristics Mirena: Bayer plc. Available at: http:\/\/www.medicines.org.uk\/emc\/medicine\/1829\/SPC\/Mirena. Accessed July 1,\u00a02013."}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:16:59Z","timestamp":1758010619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214022985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0015028214022985"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.10.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725289814.793505355","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}